General Information of the Compound
Compound ID
CP0298955
Compound Name
1-Benzyl-4-[3-(methylsulfonyl)phenyl]piperazine
    Show/Hide
Synonyms
1-Benzyl-4-[3-(methylsulfonyl)phenyl]piperazine
CHEMBL597413
    Show/Hide
Structure
Formula
C18H22N2O2S
Molecular Weight
330.453
Canonical SMILES
CS(=O)(=O)c1cccc(c1)N1CCN(Cc2ccccc2)CC1
    Show/Hide
InChI
InChI=1S/C18H22N2O2S/c1-23(21,22)18-9-5-8-17(14-18)20-12-10-19(11-13-20)15-16-6-3-2-4-7-16/h2-9,14H,10-13,15H2,1H3
    Show/Hide
InChIKey
DABGEKAEKHHGFN-UHFFFAOYSA-N
Physicochemical Property
logP
2.4123
Rotatable Bonds
4
Heavy Atom Count
23
Polar Areas
40.62
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
4
Complexity
23

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 45380179
SID: 93371815
ChEMBL ID
CHEMBL597413
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01005, D(2) dopamine receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  2
1
Ki = 431 nM
   TI
   LI
   LO
   TS
2
Ki = 1923 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( 1-Benzyl-4-[3-(methylsulfonyl)phenyl]piperazine )
Drug Name 1-Benzyl-4-[3-(methylsulfonyl)phenyl]piperazine
Target(s)
Dopamine D2 receptor (D2R)
Inhibitor